飞利浦(PHG)
icon
搜索文档
Philips Zenition 90 Motorized receives FDA 510(k) clearance, helping clinicians deliver high quality care with a high-powered and fast motorized mobile C-arm
GlobeNewswire News Room· 2024-06-17 21:00
June 17, 2024 Intuitive motorization for greater control and high-power (25 kW [1]) for state-of-the-art image quality supports complex vascular needs and a full range of clinical proceduresAutomated workflows contribute to greater flexibility and independence for clinicians, providing more time to focus on achieving the best possible outcomes for patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guid ...
Philips (PHG) Aids Image-Guided Treatment With New Stent System
ZACKS· 2024-06-13 23:19
Philips’ (PHG) shares have gained 16.6% in the year-to-date period, outperforming the Zacks Medical sector’s growth of 5.3%. The company is benefiting from a strong Diagnosis & Treatment segment, driven by its Precision Diagnosis and Image-Guided Therapy businesses. Hence, the company is making concerted efforts to strengthen these businesses.In this regard, Philips’ recent launch of the Duo Venous Stent System in a bid to boost its Image-Guided Therapy portfolio remains noteworthy.The Duo Venous Stent Syst ...
Philips launches Duo Venous Stent System for treatment of symptomatic venous outflow obstruction
Newsfilter· 2024-06-12 21:00
June 12, 2024                                                                                                                                                                Sanger Heart & Vascular Institute, Atrium Health, treated the first patient with the new implantable medical device following FDA premarket approval Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, today announced the first implant of the Duo Venous Stent System, an implantable med ...
Philips (PHG) Boosts Precision Diagnosis With AI Platform
ZACKS· 2024-06-06 00:41
Philips’ (PHG) shares have gained 17.6% in the year-to-date period, outperforming the Zacks Medical sector’s growth of 4.3%. The company is benefiting from strong momentum in the Diagnosis & Treatment segment on the back of its strengthening Precision Diagnosis portfolio powered by artificial intelligence (AI).The company’s latest launch of an AI-enabled cardiovascular ultrasound platform testifies to the aforesaid fact.This FDA 510(k) cleared AI platform combines Philips’ EPIQ CVx and Affiniti CVx ultrasou ...
Deep integration of proven AI tools into Philips cardiovascular ultrasound systems to better diagnose more cardiac disease patients
Newsfilter· 2024-06-04 21:00
June 4, 2024 New FDA-cleared AI-enabled applications include the industry's first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds First fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heart valve disease Amsterdam, the Netherlands – Roya ...
Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations
Newsfilter· 2024-05-30 21:00
May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico's Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its economic and sustai ...
Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations
GlobeNewswire News Room· 2024-05-30 21:00
May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico's Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its economic and sustain ...
Philips (PHG) Boosts Medical Imaging Footprint With New Move
zacks.com· 2024-05-30 00:26
Philips (PHG) is leaving no stone unturned to strengthen its footprint in the global medical imaging market on the back of a growing customer base. Per a Mordor Intelligence report, the global medical imaging market is expected to witness a CAGR of 4.9% between 2024 and 2030.Recently, the company announced the wide availability of its VeriSight Pro 3D Intracardiac Echocardiography catheter to several Hong Kong hospitals, thereby expanding clientele for its ICE imaging technology.Philips' VeriSight Pro 3D IC ...
Here's Why Royal Philips (PHG) is a Strong Value Stock
zacks.com· 2024-05-24 22:45
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style Score ...
Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt
globenewswire.com· 2024-05-24 04:31
May 23, 2024  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the “Notes”) under its European Medium Term Note (EMTN) program. The issue of the Notes will have a debt-neutral effect, as the net proceeds of the transaction will be used for repayment of debt in 2024 and 2025. The issue price for the Notes is 98.257% with a Coupon of 3.75%, resulting in a ...